Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Clinical significance of plasmacytosis in the day+14 bone marrow of patients with acute myeloid leukaemia undergoing induction chemotherapy.

Al-Shughair N, Al-Dawsari G, Gyger M, Mohamed G, Roberts G.

J Clin Pathol. 2007 May;60(5):520-3. Epub 2006 May 26.

PMID:
16731597
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.

Kern W, Haferlach T, Schoch C, Loffler H, Gassmann W, Heinecke A, Sauerland MC, Berdel W, Buchner T, Hiddemann W.

Blood. 2003 Jan 1;101(1):64-70. Epub 2002 Jun 28.

PMID:
12393605
[PubMed - indexed for MEDLINE]
Free Article
3.

Bone marrow microvessel density and its prognostic significance in AML.

Rabitsch W, Sperr WR, Lechner K, Chott A, Prinz E, Valent P, Kalhs P.

Leuk Lymphoma. 2004 Jul;45(7):1369-73.

PMID:
15359635
[PubMed - indexed for MEDLINE]
4.

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow.

Maurillo L, Buccisano F, Spagnoli A, Del Poeta G, Panetta P, Neri B, Del Principe MI, Mazzone C, Consalvo MI, Tamburini A, Ottaviani L, Fraboni D, Sarlo C, De Fabritiis P, Amadori S, Venditti A.

Haematologica. 2007 May;92(5):605-11.

PMID:
17488683
[PubMed - indexed for MEDLINE]
Free Article
5.

Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.

Chantry AD, Snowden JA, Craddock C, Peggs K, Roddie C, Craig JI, Orchard K, Towlson KE, Pearce RM, Marks DI; BSBMT Clinical Trials Committee.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1310-7.

PMID:
17162213
[PubMed - indexed for MEDLINE]
6.

Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.

Vial JP, Tabrizi R, Pigneux A, Lacombe F, Praloran V, Belloc F.

Cytometry B Clin Cytom. 2006 May;70(3):115-23.

PMID:
16572429
[PubMed - indexed for MEDLINE]
Free Article
7.

Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia.

Nørgaard JM, Langkjer ST, Palshof T, Pedersen B, Hokland P.

Eur J Haematol. 2001 Mar;66(3):160-7.

PMID:
11350484
[PubMed - indexed for MEDLINE]
8.

Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.

Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Nuessler V, Schmetzer H.

Eur J Haematol. 2003 Nov;71(5):366-76.

PMID:
14667200
[PubMed - indexed for MEDLINE]
9.

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.

Coustan-Smith E, Ribeiro RC, Rubnitz JE, Razzouk BI, Pui CH, Pounds S, Andreansky M, Behm FG, Raimondi SC, Shurtleff SA, Downing JR, Campana D.

Br J Haematol. 2003 Oct;123(2):243-52.

PMID:
14531905
[PubMed - indexed for MEDLINE]
10.

[Detection of residual leukemic cells after complete remission of patients with acute myeloid leukemia].

Xu YL, Zhang XZ, Zhang L, Zhang XQ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Dec;12(6):858-60. Chinese.

PMID:
15631679
[PubMed - indexed for MEDLINE]
11.

Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.

Betticher DC, Huxol H, Müller R, Speck B, Nissen C.

Exp Hematol. 1993 Nov;21(12):1517-21.

PMID:
8405233
[PubMed - indexed for MEDLINE]
12.

Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.

Tavernier E, Le QH, Elhamri M, Thomas X.

Leuk Res. 2003 Mar;27(3):205-14.

PMID:
12537972
[PubMed - indexed for MEDLINE]
13.

Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

Wells RJ, Arthur DC, Srivastava A, Heerema NA, Le Beau M, Alonzo TA, Buxton AB, Woods WG, Howells WB, Benjamin DR, Betcher DL, Buckley JD, Feig SA, Kim T, Odom LF, Ruymann FB, Smithson WA, Tannous R, Whitt JK, Wolff L, Tjoa T, Lampkin BC.

Leukemia. 2002 Apr;16(4):601-7.

PMID:
11960339
[PubMed - indexed for MEDLINE]
Free Article
14.

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.

Larson RA, Day RS, Azarnia N, Bennett JM, Browman G, Goldberg J, Gottlieb A, Grunwald H, Miller K, Raza A, et al.

Br J Haematol. 1992 Oct;82(2):337-46.

PMID:
1419816
[PubMed - indexed for MEDLINE]
15.

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.

Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dörken B, Ludwig WD.

Haematologica. 2000 Jul;85(7):711-21.

PMID:
10897123
[PubMed - indexed for MEDLINE]
Free Article
16.

Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.

Padró T, Ruiz S, Bieker R, Bürger H, Steins M, Kienast J, Büchner T, Berdel WE, Mesters RM.

Blood. 2000 Apr 15;95(8):2637-44.

PMID:
10753845
[PubMed - indexed for MEDLINE]
Free Article
17.

Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.

Demirer T, Petersen FB, Bensinger WI, Appelbaum FR, Fefer A, Rowley S, Sanders J, Chauncey T, Storb R, Lilleby K, Buckner CD.

Bone Marrow Transplant. 1996 Jul;18(1):29-34.

PMID:
8831992
[PubMed - indexed for MEDLINE]
18.

Dysmegakaryopoiesis predicting response to therapy in acute myeloid leukaemia. A histologic and clinical study.

Delacrétaz F, Spertini O, Schmidt PM, Grob JP.

Pathol Res Pract. 1991 Mar;187(2-3):290-5.

PMID:
2068013
[PubMed - indexed for MEDLINE]
19.

Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.

San Miguel JF, Martínez A, Macedo A, Vidriales MB, López-Berges C, González M, Caballero D, García-Marcos MA, Ramos F, Fernández-Calvo J, Calmuntia MJ, Diaz-Mediavilla J, Orfao A.

Blood. 1997 Sep 15;90(6):2465-70.

PMID:
9310499
[PubMed - indexed for MEDLINE]
Free Article
20.

A systematic overview of chemotherapy effects in acute myeloid leukaemia.

Kimby E, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):231-52. Review.

PMID:
11441935
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk